Navigation Links
MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
Date:11/3/2008

GAITHERSBURG, Md., Nov. 3 /PRNewswire/ -- MedImmune today announced that it has initiated a Phase 1/2a clinical trial of a live, attenuated intranasal vaccine in healthy children one month to 12 months of age to help prevent severe respiratory syncytial virus (RSV) infections. RSV is the most common respiratory infection in infants and can cause disease in otherwise healthy infants and children.

"RSV is a serious respiratory disease that can have significant effects on children. As a leader in pediatric medicine, MedImmune is committed to developing therapies that can combat the most common cause of pediatric respiratory illness," said Filip Dubovsky, M.D., M.P.H, vice president, clinical development, vaccines. "Because respiratory illness due to RSV occurs in otherwise healthy children, developing a vaccine is a public health priority."

MedImmune is a world leader in the development of innovative therapeutic biologic products for prophylaxis and prevention of infectious diseases. This Phase 1/2a clinical trial is designed to assess the safety, tolerability, immunogenicity and viral shedding of the intranasal RSV vaccine in infants and young children. It is a randomized, double-blind, placebo-controlled and multi-dose study that will enroll 320 children.

The investigational vaccine, MEDI-559, is being developed through a Cooperative Research and Development Agreement (CRADA) with the National Institute of Allergy and Infectious Diseases (NAID), part of the National Institutes of Health, to help address RSV disease in children. The vaccine was originally developed in the NAID Division of Intramural Research by a team led by Peter L. Collins, Ph.D. and Brian R. Murphy, M.D.

About RSV

RSV is the most important cause of viral lower respiratory tract illness in infants worldwide. Each year, an estimated 125,000 infants in the United States are hospitalized with severe RSV infections. RSV is the most common respiratory infection i
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
2. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
3. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
4. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
5. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
6. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
7. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
8. MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
9. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
10. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
11. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... Facet Solutions, Inc. announced today that it has... The acquisition creates an undisputed leadership ...ty and clinical experience in posterior motion pre...rom lumbar spinal stenosis," stated Facet Solution...idation further strengthens Facet Solutions, posit...
(Date:11/6/2009)... Philips Respironics applauds the efforts of the C... raise awareness about an important public health ...lease of the first-ever government study to monito... milestone in quantifying the size and scope of th...y leader and sleep therapy manufacturer, Philips R...
(Date:11/6/2009)...Newswire/ -- Chimerix, Inc., a biopharmaceutical c...eutics to address life-threatening diseases, prese...ead antiviral compound, CMX001, to the World Healt...y Initiative (GHSI). CMX001 is a broad-spectrum a...f smallpox, as well as other serious viral infecti...
Breaking Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Simple measures may prevent transmission of stomach ulcer bacteria 49935 1West Coast needs more research on fisheries marine science climate change 8987 1West Coast needs more research on fisheries marine science climate change 8987 2First Ever Egg Donor Web Portal Becomes One of The Largest Resources for Aspiring Parents in the U S 12769 1First Ever Egg Donor Web Portal Becomes One of The Largest Resources for Aspiring Parents in the U S 12769 2
...c. (Nasdaq: CADX ), a biopharmaceutical company f...ing proprietary product candidates principally,for...cial results for the,third quarter and nine months...ided an update on the clinical development,program...avance(TM), an,intravenous formulation of acetamin...
...Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharm...nced top-line results from its Phase 1 clinical,tr...ts with solid tumors,showing that picoplatin achie... given by the oral route. The results demonstrated...as linear at doses below 200 mg, and that,maximum ...
Other Medicine Technology:Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 2Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 3Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 4Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 5Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 6Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 7Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 8Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin 2Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin 3Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin 4
(Date:11/8/2009)...-USNewswire/ -- The American Public Health Associa...rovisions in the health reform bill passed last ni..., the House takes important steps toward universal...and moving our health system from one that focuses...ng people healthy," said Georges C. Benjamin, MD, ...
(Date:11/8/2009)...ealth Care Reform Bill ,, Critical legislatio...all Americans ,, HARRISBURG, Penn., Nov. 8 /PR...ht the United States House of Representatives pass...uld strengthen Medicare for seniors and end discri...ns of Americans out of affordable health coverage....
(Date:11/8/2009)...otes self-assurance, research finds , , ... have been right when she told you to sit up strai... make you feel more confident about your thoughts....aight gives a good impression to other people," Ri...gy professor at Ohio State University, said in a u...
(Date:11/8/2009)...of Health holds open house at Victoria campus , ...er 8, 2009 -- UCW Academy of Health invites anyone...uo;s health care industry to attend their open hou... ,UCW Academy of Health, which offers diplomas in ...ervices, designs its programs to meet the needs of...
(Date:11/8/2009)...the game later, doctors say , , SUNDAY, ...alk of the NFL this season, sidelining such stars ... Parker. , Officials at the American Podiatric ...ric Sports Medicine are warning athletes to take c...football and lacrosse. , "Many fall sports athl...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:Good Posture May Inspire Confidence 2Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Rx for Fall Foot Injuries 2
...itute of Mental Health currently conducting a stud...tment for Body Dysmorphic Disorder. Hollywood isn...eveloping into a crisis. BDD is similar to other ... New York, NY (PRWEB) August 2, 2008 -- In an ...
...for,Disease Control and Prevention,s (CDC) long an...HIV infections will be revealed on Aug. 3 in a pap...l Association (JAMA). The,revised estimated number...006 will replace the current, widely reported,esti...
...,(Nasdaq: GXDX ), a specialized laboratory servic...am and Laurence R. McCarthy, Ph.D. to its Board of...tham has been elected to,serve as a Class I direct...en elected to serve as a Class II director of,Geno...
... of cell death improves cancer therapy efficacy ,...one of the most aggressive types of brain tumor, h...ical studies indicated therapeutics inhibiting a g...ted clinical success only a small proportion of p...
...nt and anticipation. It also can be a time of anxi...abetes. Pregnancy in women who have diabetes is au...to-read booklet has information to help women with...information about checking and controlling blood g...
... neurodegenerative diseases, study says , ...dence that the adult human brain has the ability t...nd Clinic Lerner Research Institute. , The study i... surround and protect nerves. When the myelin is d...
Other Medicine News:Health News:Has Hollywood's Diet Obsession Forced the US Government to Take Action? 2Health News:Has Hollywood's Diet Obsession Forced the US Government to Take Action? 3Health News:Estimate of Annual HIV Incidence Increases Significantly; New Estimate Will Show Need For a National AIDS Strategy 2Health News:Estimate of Annual HIV Incidence Increases Significantly; New Estimate Will Show Need For a National AIDS Strategy 3Health News:Genoptix Announces the Addition of New Members to Board of Directors 2Health News:Genoptix Announces the Addition of New Members to Board of Directors 3Health News:JCI online early table of contents: Aug. 1, 2008 2Health News:JCI online early table of contents: Aug. 1, 2008 3Health News:JCI online early table of contents: Aug. 1, 2008 4Health News:JCI online early table of contents: Aug. 1, 2008 5Health News:JCI online early table of contents: Aug. 1, 2008 6Health News:JCI online early table of contents: Aug. 1, 2008 7Health News:Neurons Can Re-Grow in Some MS Lesions 2
...lades are designed with the clinician in mind. The...to simplify cleaning - no crevices or hard to reac...crews that can be misplaced. The bright focused bl...ber optic systems manufactured to ISO 7376-3. Trad...
...lades are designed with the clinician in mind. The...to simplify cleaning - no crevices or hard to reac...crews that can be misplaced. The bright focused bl...ber optic systems manufactured to ISO 7376-3. Trad...
Fiberoptic Green System Blade Miller Oxiport
...of the vocal cords in even the most difficult case...e a standard laryngoscope, Viewmax® does not r...tage lies in its ability to allow intubation wheth...irway. It has a patented lens system that refracts...
Medicine Products: